The company is a limited-liability corporation reorganizedon the basis of " China High-Tech ( Group ) Co." which wasestablished in June 1992. The Company's A shares was listedon Shanghai Stock Exchange on July 26, 1996. It is engaged in industrial investment and venture capital in biomedicine, electronics, communications and other high-tech sectors and international trade. The "external recombinant soluble staphylococcal enzyme" researched and developed by a subsidiary acquired the national class A bio-clinical innovative drug approval, also is China's first class A biological anti-infective drugs with independent intellectual property rights.
Headquarters
8th Floor, Zhongguancun Founder Building, No. 298 Chengfu Road, Haidian District, Beijing
Beijing; Beijing;
Postal Code: 100080
Contact Details: Purchase the China Hi-Tech Group Co.,Ltd report to view the information.
Website: http://www.chinahitech.com.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service